COSCIENS Biopharma Inc. Form 20-F/A: Amended annual report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2024-07-17: Form 20-F/A; Period of report 2023-12-31; Description Annual report of foreign private issuer; Document form20-fa.htm.
- 2024-02-15: Form 20-F/A; Period of report 2022-12-31; Description Annual report of foreign private issuer; Document form20-fa.htm.
- 2020-06-18: Form 20-F/A; Period of report 2019-12-31; Description Annual report of foreign private issuer; Document form20-fa.htm.
- 2019-07-26: Form 20-F/A; Period of report 2018-12-31; Description 20-F/A; Document a19-13252_120fa.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2024-07-17 | 20-F/A | 2023-12-31 | Annual report of foreign private issuer | form20-fa.htm |
| 2024-02-15 | 20-F/A | 2022-12-31 | Annual report of foreign private issuer | form20-fa.htm |
| 2020-06-18 | 20-F/A | 2019-12-31 | Annual report of foreign private issuer | form20-fa.htm |
| 2019-07-26 | 20-F/A | 2018-12-31 | 20-F/A | a19-13252_120fa.htm |